| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A New and Improved Experimental Design for the Discrete Choice Experiment Module of the EuroQol Valuation Technology Protocol
|
Jonker, Marcel F.
|
|
|
27 |
10 |
p. 1311-1317
|
artikel
|
| 2 |
A Tutorial on Value-Based Adaptive Designs: Could a Value-Based Sequential 2-Arm Design Have Created More Health Economic Value for the Big CACTUS Trial?
|
Flight, Laura
|
|
|
27 |
10 |
p. 1328-1337
|
artikel
|
| 3 |
Author Reply
|
Silfverschiöld, Maria
|
|
|
27 |
10 |
p. 1468
|
artikel
|
| 4 |
Author Reply
|
Rebba, Vincenzo
|
|
|
27 |
10 |
p. 1467
|
artikel
|
| 5 |
Cost-of/Burden-of-Illness Studies: Steps Backward?
|
Rittenhouse, Brian E.
|
|
|
27 |
10 |
p. 1466-1467
|
artikel
|
| 6 |
Do Behavioral Characteristics Influence the Breast Cancer Diagnosis Delay? Evidence From French Retrospective Data
|
Le Clainche, Christine
|
|
|
27 |
10 |
p. 1408-1416
|
artikel
|
| 7 |
Does Willingness to Pay Differ for Mental and Physical Health?
|
Eaton, Eleanor
|
|
|
27 |
10 |
p. 1417-1425
|
artikel
|
| 8 |
Editorial Board
|
|
|
|
27 |
10 |
p. iv
|
artikel
|
| 9 |
Examining the Impact of Structural Uncertainty Across 10 Type 2 Diabetes Models: Results From the 2022 Mount Hood Challenge
|
Altunkaya, James
|
|
|
27 |
10 |
p. 1338-1347
|
artikel
|
| 10 |
Generating Utilities for the Château-Santé Base: A Novel, Generic, and Patient-Centered Health-Outcome Measure
|
Zhang, Xin
|
|
|
27 |
10 |
p. 1426-1435
|
artikel
|
| 11 |
Guiding Principles for Evaluating Vaccines in Joint Health Technology Assessment in the European Union: Preparing for the European Union’s Regulation on Health Technology Assessment for Vaccines
|
Largeron, Nathalie
|
|
|
27 |
10 |
p. 1318-1327
|
artikel
|
| 12 |
Integrating Price Benchmarks and Comparative Clinical Effectiveness to Inform the Medicare Drug Price Negotiation Program
|
Sullivan, Sean D.
|
|
|
27 |
10 |
p. 1348-1357
|
artikel
|
| 13 |
Mapping the Lequesne Functional Index Into the EQ-5D-5L Utility Index in Patients With Knee Osteoarthritis
|
Dardenne, Nadia
|
|
|
27 |
10 |
p. 1400-1407
|
artikel
|
| 14 |
Market Entry Agreements for Innovative Pharmaceuticals Subject to Indication Broadening: A Case Study for Pembrolizumab in The Netherlands
|
Heine, Renaud J.S.D.
|
|
|
27 |
10 |
p. 1367-1372
|
artikel
|
| 15 |
Patient-Reported Outcome Measures as an Intervention: A Comprehensive Overview of Systematic Reviews on the Effects of Feedback
|
Wittich, Laura
|
|
|
27 |
10 |
p. 1436-1453
|
artikel
|
| 16 |
Predicting the Population Health Economic Impact of Current and New Cancer Treatments for Colorectal Cancer: A Data-Driven Whole Disease Simulation Model for Predicting the Number of Patients with Colorectal Cancer by Stage and Treatment Line in Australia
|
Degeling, Koen
|
|
|
27 |
10 |
p. 1382-1392
|
artikel
|
| 17 |
Remote-Use Applications of the Amyotrophic Lateral Sclerosis Functional Rating Scale-Revised Clinical Outcome Assessment Tool: A Scoping Review
|
Bhushan, Nivedita L.
|
|
|
27 |
10 |
p. 1454-1465
|
artikel
|
| 18 |
Sales Revenues for New Therapeutic Agents Approved by the United States Food and Drug Administration From 1995 to 2014
|
Wouters, Olivier J.
|
|
|
27 |
10 |
p. 1373-1381
|
artikel
|
| 19 |
Table of Contents
|
|
|
|
27 |
10 |
p. i-iv
|
artikel
|
| 20 |
Traditional Methods Hold Their Ground Against Machine Learning in Predicting Potentially Inappropriate Medication Use in Older Adults
|
Chiu, Yohann Moanahere
|
|
|
27 |
10 |
p. 1393-1399
|
artikel
|
| 21 |
Uncertainty in Long-Term Relative Effectiveness of Medicines in Health Technology Assessment
|
Versteeg, Jan-Willem
|
|
|
27 |
10 |
p. 1358-1366
|
artikel
|
Tijdschrift beschrijving